The positive sentiment engendered by Merck 's (NYSE: MRK) solid third-quarter results posted on Thursday carried over into the following trading session. It wasn't only the vibes; several analysts tracking the durable pharmaceutical company raised their price targets on its equity. The stock climbed more than 2% as a result, in contrast to the S&P 500 index's relatively steep decline of 1. 8%.
POLARIS INSIGHTS